Gene SCC-112 and diagnostic and therapeutic uses thereof
US7351811B2 · kind B2 · utility
0Cited by
52References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2003 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Dec 14, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A gene that is a modulator of tumor growth and metastasis in certain cancer types is provided. SCC-112 (about 150 kDa) and/or a mutant form of SCC-112 (about 65 kDa) is a tumor suppressor molecule. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of SCC-112 such as breast and kidney cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.